(Janus) Bill Gross' July 2017 Investment Outlook is now available.

Bill Gross' July 2017 Investment Outlook is now available.

“Kill the Umpire”, the fan cried to open the 1996 baseball season in Cincinnati, and 7 pitches later, the man behind the plate, John McSherry, was dead, all 320 pounds of him screaming for more oxygen to feed his struggling heart. He’d been killed by his poor health, by a billion molecules of sink-clogging cholesterol that fed on his coronary artery and sucked up his life’s blood like a vampire at midnight. The next day Howard Stern had characteristically railed that the antidote was obvious. It was the same for all fat people: “DON’T EAT”, he howled. As if the ump hadn’t known. The fact was he couldn’t stop. He loved the taste of food – every sugary, starchy, carbohydrated morsel. The first bite was an ecstasy, as was the last, and everything in between. The man, it seemed, was a Cuisinart with 4 limbs.

Franz Kafka wove a tale 100 years earlier that was a mirror image of McSherry’s tragedy. His “A Hunger Artist” described a professional faster – a sideshow freak in 19th century Europe who attracted attention and spare coins by withering away inside a wooden cage. The gapers marveled at his shriveled skeleton – stuck their hands through the bars to nudge his bony ribs – and awed at his resolve to starve himself to the precipice of self-extinction. “I always wanted you to admire my fasting”, said the hunger artist, “but you shouldn’t have. (The fact is) I have to fast, I can’t help it. I couldn’t find the food I liked. If I had found it, believe me, I would have made no fuss and stuffed myself like you or anyone else.”

Well, well – one man who couldn’t stop and another one who couldn’t start – eating, that is. Their stories, though, are really not about food, but life itself – what compels us to do what we do, what forces us to act or not act, what makes us who we are. Is personal behavior, though, really beyond our control? Shakespeare would retort that the fault lies not in our stars, but in ourselves, and I applaud that – strong-willed 175-pound guy that I am. But, on the other hand, who are we other than a morphous, gelatinous blob of moving flesh and bone that’s been molded primarily without our input, first by genes, and then by environment into the living person we know as ourselves? Are we all just walking Cuisinarts, or better yet, mobile computers with consciousness?

To my mind, free will is the key to our unique position among life’s animals. Without it, this business of living is reduced to a meaningless game.

A TIME Magazine cover story once asked, “Can machines think?” and if they can, it might well have asked the corollary, “Are people machines?” The fact is that sophisticated modern machines can do just about anything a human being can do. TIME suggested that the difference between “us” and “them” was a human being’s consciousness. We are “aware” whereas they are not. But even if that is true, to me it’s not enough. Who wants to be a machine that simply knows it’s a machine? Who wants to walk the Earth as a preprogrammed robot with no input as to his or her final fate? To my mind, free will is the key to our unique position among life’s animals. Without it, this business of living is reduced to a meaningless game. Unless the John McSherrys of the world can stop eating and the hunger artists can start, we might as well just turn out the lights.

Monetary policy in the post-Lehman era has resembled the gluttony of long departed umpire John McSherry – they can’t seem to stop buying bonds, although as compulsive eaters and drinkers frequently promise, sobriety is just around the corner.

Monetary policy in the post-Lehman era has resembled the gluttony of long departed umpire John McSherry – they can’t seem to stop buying bonds, although as compulsive eaters and drinkers frequently promise, sobriety is just around the corner. To date, since the start of global Quantitative Easing, over $15 trillion of sovereign debt and equities now overstuff central bank balance sheets in a desperate effort to keep global economies afloat. At the same time, over $5 trillion of investment grade bonds trade at negative interest rates in what can only be called an unsuccessful effort to renormalize real and nominal GDP growth rates. The adherence of Yellen, Bernanke, Draghi, and Kuroda, among others, to standard historical models such as the Taylor Rule and the Phillips curve has distorted capitalism as we once knew it, with unknown consequences lurking in the shadows of future years.

Similarly, private economists adhere to historical models, which attempt to “prove” that recessions are the result of negative yield curves, as seen in Chart 1. Over the past 25 years, the three U.S. recessions in 1991, 2000, and 2007-2009 coincided nicely with a flat yield curve between three-month Treasury Bills and 10-year Treasuries. Since the current spread of 80 basis points is far from the “triggering” spread of 0, economists and some Fed officials as well, believe a recession can be nowhere in sight.

When the Yield Curve Rolls Over

Interest rate on 10-year Treasury note minus that of three-month Treasury bill (average monthly)

Chart: Interest rate on 10-year Treasury note minus that of three-month Treasury bill (average monthly)

Source: Federal Reserve Bank of St. Louis

Perhaps. But the reliance on historical models in an era of extraordinary monetary policy should suggest caution. Logically, (a concept seemingly foreign to central bank staffs) in a domestic and global economy that is increasingly higher and higher levered, the cost of short term finance should not have to rise to the level of a 10-year Treasury note to produce recession. Most destructive leverage – as witnessed with the pre-Lehman subprime mortgages – occurs at the short end of the yield curve as the cost of monthly interest payments increase significantly to debt holders. While governments and the U.S. Treasury can afford the additional expense, levered corporations and individuals in many cases cannot. Such was the case during each of the three recessions shown in Chart 1. But since the Great Recession, more highly levered corporations, and in many cases, indebted individuals with floating rate student loans now exceeding $1 trillion, cannot cover the increased expense, resulting in reduced investment, consumption and ultimate default. Commonsensically, a more highly levered economy is more growth sensitive to using short term interest rates and a flat yield curve, which historically has coincided with the onset of a recession.

Commonsensically, a more highly levered economy is more growth sensitive to using short term interest rates and a flat yield curve, which historically has coincided with the onset of a recession.

Just as logically, there should be some “proportionality” to yield curve tightening. While today’s yield curve would require only an 85 basis increase in 3-month Treasuries to “flatten” the yield curve shown in Chart 1, an 85 basis point increase in today’s interest rate world would represent a near doubling of the cost of short term finance. The same increase prior to the 1991, 2000 and 2007-2009 recessions would have produced only a 10-20% rise in short rates. The relative “proportionality” in today’s near zero interest rate environment therefore, argues for much less of an increase in short rates and ergo – a much steeper and therefore “less flat” curve to signal the beginning of a possible economic reversal.

How flat? I don’t know – but at least my analysis shows me that the current curve has flattened by nearly 300 basis points since the peak of Fed easing in 2011/2012. Today’s highly levered domestic and global economies which have “feasted” on the easy monetary policies of recent years can likely not stand anywhere close to the flat yield curves witnessed in prior decades. Central bankers and indeed investors should view additional tightening and “normalizing” of short term rates with caution.

**The introduction to this month’s Outlook was modified from an Investment Outlook originally constructed more than a decade ago.

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
:
  • PTC -10.9%, CHRW -6.8%, ABB -3.7%, BG -3.4%, (expects Q2 adj earnings to be modestly profitable but below low end of the range of analyst estimates primarily driven by challenging ag market conditions; details $250 mln Competitiveness Program ), AA -3%, CHKP-3%, SHW -2.7%, STLD -2.2%, PM -2.1%, QCOM -2%, AXP -1.7%, SAP-1.6%, TRV -1.2%, SON -0.8%
Other news:
  • CFRX -13.8% (commences public offering of its common stock and warrants to purchase additional shares of its common stock; all of the securities in the offering are to be sold by ContraFect)
  • GOOD -6.3% (to sell shares of its common stock in an underwritten public offering)
  • WES -5.9% (being attributed to block trade pricing)
  • INO -4.9% (prices offering of 12.5 mln shares of common stock at $6.00 per share)
  • RGLS -2.1% (prices 44 mln shares of common stock at $0.91 per share)
  • FND -0.5% (prices 10,718,550 common stock offering by selling stockholders)
Analyst comments:
  • FMSA -7% (downgraded to Sell from Neutral at Goldman)
  • RNG -1.3% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
  • PFE -0.6% (downgraded to Neutral from Outperform at Credit Suisse)

>>> SHLM - Cuts FY17 $1.60-1.70 v $2.02e (previous $2.08-2.18), adj EBITDA $200

Cuts FY17 $1.60-1.70 v $2.02e (previous $2.08-2.18), adj EBITDA $200-204M ((prior adj EBITDA $225-230M), Citing margin compression "While our volumes in Europe remain on track with our expectations, we are incurring significant margin pressure in the region due to the magnitude and timing of raw material cost increases," said Joseph M. Gingo, chairman, president and chief executive officer. "This compression compounds the macroeconomic headwinds and previously disclosed operational challenges thus making our full-year guidance unattainable, despite the continued progress we are making in this reset year.

--> Potential -ve read across for Faurecia, Scaheffler Valeo, Plastic omnium

WSJ : BP Said to Approach Possible Buyers for North Sea Assets

BP Said to Approach Possible Buyers for North Sea Assets
Potential purchasers include private-equity firms, say people familiar with the matter

LONDON— BP BP 0.57% PLC has approached potential buyers of its oil-and-gas production assets in the North Sea, people familiar with the matter said, around 50 years after the once-state-owned company helped pioneer deepwater extraction there.

Some of the people said the talks included essentially the full range of BP’s currently producing assets in the North Sea, where the London-based company is the top producer. The potential buyers include private-equity firms, the people said.

The discussions are at an early stage, the people said, and the value of the assets isn’t clear.

“At the minute, there’s been initial conversations,” one of the people said.

BP said it remained “committed to the U.K. North Sea, and any rumors to the contrary are simply false.” The company said it was in the middle of a plan to ramp up its U.K. North Sea production to 200,000 barrels a day and pointed to important new developments there west of the Shetland Islands.

“Our aim is to sustain a material business in the region for decades to come,” BP said.

It isn’t clear how much of BP’s North Sea assets the company would be willing to part with. In addition to its North Sea assets that produce at least 140,000 barrels a day, the company has other North Sea projects that are planned to come online in future.

North Sea production peaked in the 1990s and it has become more expensive to extract the remaining barrels from aging fields. Production began declining after 2000, although it recently perked up, after a series of government tax breaks encouraged investment.

Any move to sell a large portion of its North Sea assets would be a departure for BP. The company has been a leader in the North Sea since the mid-1960s, when exploration and production began, helping make the region one of the world’s great petroleum basins.

Like other big oil companies, BP has been reviewing its assets after a three-year rout in oil prices, with high-cost regions including the North Sea particularly in focus. It already sold part of its interest in the North Sea’s Magnus field to EnQuest PLC earlier this year.

Royal Dutch Shell PLC, previously the region’s top producer, halved its North Sea output after striking a $3.8 billion deal with private-equity backed Chrysaor in January.

“The majors have reduced spend because they can’t get the returns in the North Sea compared to more attractive, lower-cost opportunities globally,” such as Brazilian deep water and U.S. shale, said Fiona Legate, an analyst at Wood Mackenzie, the Scottish energy consultancy.

Wood Mackenzie forecasts U.K. production will rise to 1.87 million barrels a day in 2017, from 1.67 million a day last year, as a result of new developments starting up and increased production efficiencies.

“Without material discoveries going forward we’d expect production to go back into terminal decline around 2018 in the U.K.,” said Ms. Legate.

Private-equity firms are coming in and extending production on fields and “that happening more often will add up and help squeeze those extra barrels out from the North Sea,” added Ms. Legate.

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
:
  • HPJ +19.5%, SRPT +18%, DWCH +6.3%, PLXS +6.1%, KMI +4%, HAWK+3.9%, URI +3.6%, TMUS +2.9%, VMI +2.5%, AEHR +2.4%, ABT +1.2%,DOV +1%, EWBC +0.9%, KEY +0.7%, UN +0.7%, FPI +0.6%
M&A news:
  • AVA +18.1% (Avista to be acquired by Hydro One for $53/share), CAMT +5.2% (to sell its PCB business for $35 million)
Other news:
  • BVXV +10.6% (reports results from the Phase 2b clinical trial of M-001)
  • ALIM +6.6% (announced that the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) has given final approval to reduce the size of its ILUVIEN Registry Safety Study)
  • AEZS +4.7% (continued strength)
  • MGM +2.8% (to join S&P 500)
  • ERIC +1.8% (slightly rebounding following recent weakness post earnings)
  • RMD +1% (to join S&P 500)
  • STM +1% (says recent media speculation that it may resume taking MCU orders after year-end is false)
  • TEVA +0.9% (receives NICE recommendation for CINQAERO)
Analyst comments:
  • NKE +2.3% (upgraded Overweight from Equal-Weight at Morgan Stanley; tgt $68)
  • BGS +2.1% (upgraded to Buy from Neutral at Citigroup)
  • RCL +0.6% (upgraded to Overweight from Neutral at JP Morgan)

>>> US Early premarket gappers

Early premarket gappers
Gapping up:
  • HPJ +19.5%, AVA +18.3%, SRPT +17.5%, ALIM +6.6%, DWCH +6.3%,PLXS +6.1%, HAWK +3.9%, KMI +3.7%, URI +3.6%, KEY +3.6%, MGM+3%, TMUS +3%, VMI +2.5%, AEHR +2.4%, NKE +2.3%, ERIC +2.1%, RMD+1%, DOV +1%, EWBC +0.9%, TEVA +0.8%, GSK +0.7%, FPI +0.6%, UN+0.6%, NURO +0.5%
Gapping down:
  • PTC -12.6%, CFRX -10.3%, CHRW -6.8%, GOOD -6.3%, WES -6%, INO-4.9%, ABB -3.7%, BG -3.4%, CHKP -2.4%, STLD -2.2%, QCOM -2.2%,RGLS -2.1%, AA -1.8%, AXP -1.7%, SAP -1.6%, TRV -1.2%, SON -0.8%,PM -0.6

>>> Sherwin-Williams misses by $0.04, misses on revs; guides Q3 EPS in-line; gui

Sherwin-Williams misses by $0.04, misses on revs; guides Q3 EPS in-line; guides FY17 EPS in-line
  • Reports Q2 (Jun) earnings of $4.52 per share, excluding Valspar-related costs, $0.04 worse than the Capital IQ Consensus of $4.56; revenues rose 16.0% year/year to $3.73 bln vs the $3.83 bln Capital IQ Consensus.
  • Co issues in-line guidance for Q3, sees EPS of $4.80-5.20, excluding non-recurring items, vs. $4.86 Capital IQ Consensus Estimate.
    • Anticipate Sherwin-Williams' core net sales will increase a low to mid single digit percentage compared to last year's third quarter. Expect incremental sales from the Valspar acquisition to be approximately $1.0 billion in the third quarter.
  • Co issues in-line guidance for FY17, sees EPS of $14.80-15.20, excluding non-recurring items, vs. $14.81 Capital IQ Consensus Estimate.
    • Expect Sherwin-Williams' core net sales to increase by a mid single digit percentage compared to full year 2016. Expect incremental sales from the Valspar acquisition to be approximately $2.4 billion in 2017.
    • Based on total Company borrowings, twelve-month interest expense is projected to be approximately $400 million. Incremental depreciation and amortization step-up related to Valspar acquisition purchase accounting is projected to be approximately $275 million on an annual basis. Purchase accounting inventory adjustments of $110 million are being amortized over the three months of June, July and August, 2017. The balance sheet reflects preliminary purchase accounting balances and incremental debt of $9.5 billion used to fund the acquisition.